The Abbott Government today announced a further $75 million commitment to list three new drugs on the Pharmaceutical Benefits Scheme (PBS).

Minister for Health Sussan Ley said the announcement of Lemtrada on the PBS would benefit more than 1,000 patients per year with relapsing-remitting multiple sclerosis (RRMS).

Relapsing-remitting multiple sclerosis accounts for 80 per cent of all Australians diagnosed with MS. 

“The Abbott Government is committed to ensuring new and improved medicines are made available to patients sooner and at an affordable price,” Ms Ley said.

“Patients suffering with relapsing-remitting multiple sclerosis today have easier access to the new and important medicine Lemtrada because of its listing on the PBS.”

For more details, go to: http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2015-ley029.htm